ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 152 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $48,000 | -94.1% | 16,705 | -84.2% | 0.00% | -90.2% |
| Q1 2016 | $816,000 | +388.6% | 105,648 | +460.9% | 0.04% | +583.3% |
| Q2 2015 | $167,000 | -85.1% | 18,835 | -83.4% | 0.01% | -87.2% |
| Q1 2015 | $1,121,000 | -90.9% | 113,704 | -88.7% | 0.05% | -87.9% |
| Q4 2014 | $12,301,000 | +2024.5% | 1,004,187 | +1632.2% | 0.39% | +1668.2% |
| Q3 2014 | $579,000 | -61.5% | 57,971 | -87.2% | 0.02% | -77.1% |
| Q4 2013 | $1,505,000 | +2.8% | 453,380 | -6.5% | 0.10% | +1.1% |
| Q3 2013 | $1,464,000 | – | 484,879 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |